RxDoctor Payments Data

Mary Smith, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Spokane, WANPI 1003988312

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (38.7%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Abbott at 45.3% of the total. Reporting peaked in 2023 at $10,886 and has fallen 80.8% since, to $2,087 in 2025.

$31,862in general payments, 2019–2025

Across 159 payments — averaging $200.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$14K
  • Medtronic$11K
  • Abiomed$3K
  • Atricure, Inc.$3K
  • Ancora Heart, Inc.$286
  • Baxter Healthcare$118
  • plus $64 from 2 others
$26,373in research payments, 2019–2025

Across 21 payments — averaging $1255.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$26K

What the payments were for

  • Consulting fees$5,25016%
  • Speaking & faculty fees$12,31939%
  • Travel & lodging$8,57827%
  • Food & beverage$5,71518%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott65$14,446
Medtronic(2 entities)32$11,394
Abiomed32$3,031
Atricure, Inc.21$2,521
Ancora Heart, Inc.6$286
Baxter Healthcare1$118
Edwards Lifesciences1$51
Biohaven Pharmaceuticals, Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$31,862 in reported general payments places this provider in the 85th percentile of 105 thoracic surgery (cardiothoracic vascular surgery) providers in Washington.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Washington

Medicare billing

Part B allowed, 2024
$93,561
Medicare patients
53
Services billed
313

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Spokane

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →